Incitted financially to prescribe in the generics, biosimular directory and to respect the recommendations, doctors, in 2024, largely fulfilled the objectives set by health insurance.
Prescription efficiency indicators, “Key component for spending control and good allocation of health insurance resources”, are green, indicates the paying organization which has just published the amounts of remuneration on public health objectives (ROSP) and structure package paid to doctors for the year 2024. Thus, the prescription in the state repertoire (first indicator) increases very sharply (+ 7.4 points, 95 %) and exceeds the target target of 94 %. The prescription in the antihypertensive directory (second indicator: + 1.2 %) and more generally in the rest of the generic repertoire (indicators 3: + 0.6 %) is also up, which represents “2.1 million and 20.8 million boxes prescribed in the repertoire”, According to health insurance.
Similarly, the prescription of biosimilars of glargine insulin (the only indicator for biosimilars) continues to increase (+ 4.3 %) and remains above the target target of 40 %. “Between December 2019 and December 2024, the prescription of biosimilars increased from 19.7 % to 48.5 %”, Indicates health insurance. As a reminder, insulin is one of the biosimilars that the pharmacist does not have the right to substitute.
Incited to comply with recommendations, doctors still prescribe too many PPIs in an inappropriate manner (in patients under 65 years of age without measurable risk factor of induced digestive lesions), at 29.6 % for a target of less than 17 %. Doctors do not prescribe enough Metformin in first intention in monotherapy in type 2 diabetes (83.3 % for a target> 90 %).
-In terms of prevention, health insurance observes a degradation of the indicator on the number of antibiotic treatments in 16-65 year olds (+ 1 %) but doctors prescribe less antibiotics, particularly generating antibiotic resistance (-0.6 %). Antigrippal vaccination is decreasing among doctors (-1.8 % among those over 65 and -3.7 % for people at risk).
These indicators, accumulated to other clinical practice indicators, make it possible to calculate the ROSP of the attending physician of the adult which amounts, in 2024, to 5,361 euros on average per general practitioner (+ 3.4 %). The envelope for this field of health insurance amounts to 265 million euros in 2024. With the other plans, the average remuneration of doctors increased by 2.6 % (9,563 euros on average per general practitioner). The model will change in 2026 with the new medical agreement.
For pharmacists, health insurance presented at the end of April the figures for the remuneration of pharmacies for the past year.
